awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q44115102-15F4DBAB-D26E-43CE-B6CF-65A7760CCFE7
Q44115102-15F4DBAB-D26E-43CE-B6CF-65A7760CCFE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44115102-15F4DBAB-D26E-43CE-B6CF-65A7760CCFE7
Sustained cholinesterase inhibition in AD patients receiving rivastigmine for 12 months.
P304
Q44115102-15F4DBAB-D26E-43CE-B6CF-65A7760CCFE7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q44115102-15F4DBAB-D26E-43CE-B6CF-65A7760CCFE7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c7d56d8bfe747f676737349f95a577b4a4799c2b
P304
563-572
http://www.w3.org/2001/XMLSchema#string